EDGAR V. ALLEN, M.D., F.A.C.P.; EDGAR A. HINES JR., M.D., F.A.C.P.; WALTER F. KVALE, M.D., F.A.C.P.; NELSON W. BARKER, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
Six years have elapsed since the first report on the clinical use of dicumarol.1 Since that time there have been a number of clinical reports by ourselves and others. The literature has been reviewed previously.2, 3 It is the purpose of this presentation to consider this new therapeutic tool in the light of six years' experience.
Dicumarol is a pure chemical compound which may be recovered from spoiled sweet clover and which has been prepared synthetically. The discovery that it is the agent which causes spoiled sweet clover disease of animals which is characterized by hemorrhage, the determination of its
ALLEN EV, HINES EA, KVALE WF, et al. THE USE OF DICUMAROL AS AN ANTICOAGULANT: EXPERIENCE IN 2,307 CASES*. Ann Intern Med. 1947;27:371–381. doi: https://doi.org/10.7326/0003-4819-27-3-371
Download citation file:
Published: Ann Intern Med. 1947;27(3):371-381.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use